¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ : 2024-06-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ : 2024-06-22
±³À°ÀÏÀÚ : 2024-06-22
±³À°Àå¼Ò : ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ 2Ãþ »õ¸¸±ÝȦ

±³À°ÁÖÁ¦ : Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ

ÁÖÃÖ±â°ü : Çѱ¹°£´ãÃé¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹ÃéÀå¿Ü°úÇÐȸ

´ã´çÀÚ : õÇöÁÖ
¿¬¶ôó : 02-0000-0000

À̸ÞÀÏ : kpsc2004@gmail.com

±³À°Á¾·ù : ¿Ü°ú

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ÀüºÏƯº°ÀÚÄ¡µµ
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í Àüü Âü°¡ÀÚ 50000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 09:00~09:20 Neoadjuvant chemotherapy for resectable pancreatic cancer - current status ±è±ÔÇ¥(¿ï»êÀÇ´ë Á¾¾ç³»°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 09:20~09:40 The resectability of pancreatic cancer after neoadjuvant treatment: a radiological perspective ÇѽÂö(¼º±Õ°üÀÇ´ë ¿µ»óÀÇÇаú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 09:40~10:00 Histopathological tumor response scoring in resected pancreatic cancer following neoadjuvant therapy ÀÌ°æºÐ(¼­¿ïÀÇ´ë º´¸®°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 10:00~10:20 Impact of surgical resection after preoperative chemotherapy for metastatic pancreatic cancer Ȳȣ°æ(¿¬¼¼ÀÇ´ë ¿Ü°ú)

Åä·Ð 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 10:20~10:40 Discussion È«½Â¼ö(¿¬¼¼ÀÇ´ë ¿Ü°ú)

ÈÞ½Ä 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 10:40~10:50 Coffee break ()

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 10:50~11:10 Clinical utility of NGS(Next generation sequencing) panel in pancreato-biliary cancers À̼ºÈ¯(Â÷ÀÇ´ë ¿Ü°ú)

Åä·Ð 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 11:10~11:20 Discussion À±¿ø°Ç(¼­¿ïÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 11:20~11:30 ±¸¿¬ ¹ßÇ¥)Role of adjuvant therapy in resected invasive intraductal papillary mucinous neoplasm of the pancreas after surgical resection: Korean multicenter study ÃÖ¹®¼®(¿¬¼¼ÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 11:30~11:40 ±¸¿¬ ¹ßÇ¥)Analysis of the effects of probiotics intake on the microbiome of bile and feces in patients with chronic cholecystitis for the treatment of future biliary tract cancer; single center, single arm, prospective clinical trial ±è¼®È¯(Ãæ³²ÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 11:40~11:50 ±¸¿¬ ¹ßÇ¥)Cost-effectiveness analysis of the revised International Association of Pancreatology (IAP) 2023 guidelines for the management of branch-duct intraductal papillary mucinous neoplasm Á¤Çý¼Ö(¼­¿ïÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 11:50~12:00 ±¸¿¬ ¹ßÇ¥)The Role of Intravenous Ferritin in Optimizing Postoperative Recovery Following Pancreaticoduodenectomy: A Multicenter, Randomized, Controlled Trial ¹Ú¼ºÀº(°¡Å縯ÀÇ´ë ¿Ü°ú)

½Ä»ç 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 12:00~13:00 Lunch ()

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 13:00~13:30 Surgical tips for advanced pancreatic cancer in open surgery ±è¼Ûö(¿ï»êÀÇ´ë ¿Ü°ú)

Åä·Ð 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 13:30~13:50 Discussion º¯À±Çü(À»ÁöÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 13:50~14:10 Updated guidelines for pancreatic cyst surveillance ÃÖ»õº°(°í·ÁÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 14:10~14:30 Repeated pancreatectomy vs. chemotherapy for isolated local recurrence of pancreatic cancer in remnant pancreas ÇÑÀοõ(¼º±Õ°üÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 14:30~14:50 Borderline resectable bile duct cancer: chemotherapy first vs. surgery first ¾ç¼®Á¤(Â÷ÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 14:50~15:10 Fee for Hepatobiliary andpancreatic surgery in the National Health Insurance System ¼º¹Î±Ô(¿ï»êÀÇ´ë ¿Ü°ú)

Åä·Ð 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 15:10~15:30 Discussion ¼ÕÈñÁÖ(Áß¾ÓÀÇ´ë ¿Ü°ú)

ÈÞ½Ä 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 15:30~15:40 Coffee break ()

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 15:40~15:55 If the Right hepatic artery has to be completely occluded after artery reconstruction for surgery of perihilar cholangiocarcinoma IIIb, what will happen next in remnant liver? ÀÌÀçÈÆ(¿ï»êÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 15:55~16:10 Incidental high-grade dysplasia of the cystic duct and margin involvement: Watch and wait or Extensive surgery ¼ÕÈñÁÖ(Áß¾ÓÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 16:10~16:25 Pseudoaneurysm after pylorus-preserving pancreaticoduodenectomy (PPPD), is there no other way? À¯¼¼Çö(°í·ÁÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 16:25~16:40 Diffuse bile duct cancer portal vein & proper hepatic artery invasion ÀÌÁ¤¿ì(ÇѸ²ÀÇ´ë ¿Ü°ú)

Åä·Ð 06¿ù 22ÀÏ ÀüºÏ´ëÇб³º´¿ø Àӻ󿬱¸Áö¿ø¼¾ÅÍ »õ¸¸±ÝȦ 16:40~17:00 Discussion ±è¼ºÇö(¿¬¼¼ÀÇ´ë ¿Ü°ú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦75Â÷ Çѱ¹ÃéÀå¿Ü°úÇÐȸ Çмú´ëȸ : 2024-06-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ)2024³â ´ëÇѳëÀÎÀçÈ°ÀÇÇÐȸ ³ëÀÎÀçÈ°Àü¹®°¡ ½ÉÈ­°úÁ¤ : 2024-06-22
´ÙÀ½±Û ´ëÇѳúÇ÷°ü³»Ä¡·áÀÇÇÐȸ The 18th Annual Summer Conference on Endovascular Neurosurgical Therapy (ASCENT 2024) 2ÀÏÂ÷ : 2024-06-22
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
452 ¼­¿ï ´ëÇÑÁ¤ÇüÅëÁõÀÇÇÐȸ Á¦ 16ȸ Ãß°ÔÇмú´ëȸ : 2018-08-26 0 1,082 2018-08-22
451 ¼­¿ï Çѱ¹ÀÇÇй°¸®ÇÐȸ 2018 ¿©¸§ ÀÇÇй°¸®½ÉÈ­±³À° 2 : 2018-08-25 0 416 2018-08-22
450 ºÎ»ê µ¿¾Æ´ëÇб³ÀÇ·á¿ø ÀÓ»ó ¿µ¿ª¿¡¼­ ´Ù¾çÇÑ ÁßÀçÄ¡·á½Ã¼úÀÇ ÇöÀç¿Í ¹Ì·¡ : 2018-08-25 0 540 2018-08-22
449 °æ±â 2018³â ´ëÇѱٰ¨¼ÒÁõÇÐȸ Á¦6Â÷ Çмú´ëȸ : 2018-08-25 0 503 2018-08-22
448 ¼­¿ï Çѱ¹ÀÇÇй°¸®ÇÐȸ 2018 ¿©¸§ ÀÇÇй°¸®½ÉÈ­±³À° 1 : 2018-08-24 0 410 2018-08-22
447 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø À̺ñÀÎÈÄ°ú ±Ý¿äÁý´ãȸ : 2018-09-21 0 673 2018-08-15
446 °æ±â ÇѸ²´ë ÆòÃ̼º½Éº´¿ø ´ëÇÑ°£ÇÐȸ Extrahepatic manifestation of HBV, HBV integration: global pattern and biological function : 2018-09-20 0 4,826 2018-08-15
445 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦17Â÷ ´ëÇÑ¿¬ÇÏÀå¾ÖÇÐȸ Á¤±âÁý´ãȸ : 2018-09-19 0 971 2018-08-15
444 ¼­¿ï ´ëÇÑ°³¿ø¿µ»óÀÇÇаúÀÇ»çȸ Á¦20Â÷ °ËÁø Çмú´ëȸ ¹× Á¦15Â÷ ÃÊÀ½ÆÄ¿¬¼ö±³À° : 2018-09-16 0 1,155 2018-08-15
443 ¼­¿ï °Ç±¹´ëº´¿ø Á¦5Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ °üÀýÃÊÀ½ÆÄ ¿öÅ©¼ó : 2018-09-16 0 788 2018-08-15
442 ¼­¿ï ´ëÇÑÄ¡¸ÅÇÐȸ 2018 Ãß°è º¸¼ö±³À° : 2018-09-16 0 833 2018-08-15
441 ¿ï»ê Á¦5ȸ ¿ï»ê´ëÇб³º´¿ø ¼ÒÈ­±â³»°ú ¿¬¼ö°­Á : 2018-09-15 0 1,368 2018-08-15
440 Á¦ÁÖ ´ëÇÑÄ¡·áÃÊÀ½ÆÄÇÐȸ Á¦4ȸ Á¤±âÇмú´ëȸ : 2018-09-15 0 1,445 2018-08-15
439 ¼­¿ï Á¦74Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Çмú´ëȸ(KCR 2018) 4ÀÏÂ÷ : 2018-09-15 0 1,495 2018-08-15
438 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Çѱ¹½Å°æ¾È°úÇÐȸ Á¤±â½ÉÆ÷Áö¾ö : 2018-09-15 0 810 2018-08-15
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷